PBS updates

Fintepla (Fenfluramine)

fenfluramine hydrochloride 2.2 mg/mL oral liquid, 360 mL · ORAL · PBS code 14833Q

AUTHORITY_REQUIRED

What it costs

AU$4474.84 PBS-determined price per 1 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2025-05-01.
  • • Repeats: 5.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Severe myoclonic epilepsy in infancy (Dravet syndrome)


Patient must have (if initiating) generalised tonic-clonic seizures or generalised clonic seizures that are not adequately controlled with at least two other antiseizure medications; or

Patient must have had (if continuing) generalised tonic-clonic seizures or generalised clonic seizures that are not adequately controlled with at least two other antiseizure medications; AND

The treatment must be as adjunctive therapy to at least two other antiseizure medications; AND

Must be treated by a neurologist if treatment is being initiated; or

Must be treated by a neurologist if treatment is being continued or re-initiated; or

Must be treated by a paediatrician in consultation with a neurologist if treatment is being continued; or

Must be treated by a general practitioner in consultation with a neurologist if treatment is being continued.

Sponsor: UCB Australia Proprietary Limited ABN 48 005 799 208

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.